In vitro activity of systemic antifungal agents against Malassezia furfur
Open Access
- 1 June 1987
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 31 (6) , 951-953
- https://doi.org/10.1128/aac.31.6.951
Abstract
The activity of four antifungal agents against 15 systemic (blood and vascular catheter) and 10 superficial (skin) Malassezia furfur isolates was evaluated. MIC ranges were similar for the two groups of organisms: amphotericin B, 0.3 to 2.5 micrograms/ml; flucytosine, greater than 100 micrograms/ml; miconazole, 0.4 to 1.5 micrograms/ml; and ketoconazole, 0.025 to 0.4 micrograms/ml.This publication has 9 references indexed in Scilit:
- Methods for optimal recovery of Malassezia furfur from blood cultureJournal of Clinical Microbiology, 1986
- Catheter-Related Infection in Infants Due to an Unusual Lipophilic Yeast—Malassezia furfurPediatrics, 1985
- Malasezzia furfur sepsis in neonatesThe Journal of Pediatrics, 1985
- Systemic Malassezia furfur infections in patients receiving intralipid therapyHuman Pathology, 1985
- Broviac catheter-related Malassezia furfur sepsis in five infants receiving intravenous fat emulsionsThe Journal of Pediatrics, 1984
- In vitro and in vivo activities of ketoconazole and itraconazole against Pityrosporum orbiculareAntimicrobial Agents and Chemotherapy, 1984
- The activity in vitro of five different antimycotics against Pityrosporum orbiculareActa Dermato-Venereologica, 1979
- A Semiquantitative Culture Method for Identifying Intravenous-Catheter-Related InfectionNew England Journal of Medicine, 1977